| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 21,947 | 18,705 | ||
| Accounts receivable, net | 19,343 | 17,502 | ||
| Prepaid expenses | 1,399 | 1,421 | ||
| Inventory | 2,477 | 2,201 | ||
| Other current assets | 898 | 965 | ||
| Total current assets | 46,064 | 40,794 | ||
| Non-current accounts receivable, net | 2,454 | 3,314 | ||
| Other non-current assets, net of amortization | 743 | 768 | ||
| Total non-current assets | 3,197 | 4,082 | ||
| Total assets | 49,261 | 44,876 | ||
| Accounts payable | 5,866 | 5,941 | ||
| Accrued liabilities | 3,701 | 2,225 | ||
| Contract liability - current | 248 | 248 | ||
| Total current liabilities | 9,815 | 8,414 | ||
| Term loan | 18,206 | 18,206 | ||
| Pik interest | 1,271 | 1,271 | ||
| Debt discount | 100 | 113 | ||
| Contract liability - long-term | 24,561 | 24,561 | ||
| Total long-term liabilities | 43,938 | 43,925 | ||
| Total liabilities | 53,753 | 52,339 | ||
| Common stock, no par value unlimited shares authorized 28,062 shares issued and outstanding (2024 27,527) | 147,652 | 146,165 | ||
| Additional paid-in capital | 71,249 | 69,127 | ||
| Accumulated deficit | -224,636 | -223,998 | ||
| Accumulated other comprehensive income | 1,243 | 1,243 | ||
| Total stockholders' deficit | -4,492 | -7,463 | ||
| Total liabilities and stockholders' deficit | 49,261 | 44,876 | ||
FENNEC PHARMACEUTICALS INC. (FENC)
FENNEC PHARMACEUTICALS INC. (FENC)